Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.
Saiki S, Hatano T, Fujimaki M, Ishikawa KI, Mori A, Oji Y, Okuzumi A, Fukuhara T, Koinuma T, Imamichi Y, Nagumo M, Furuya N, Nojiri S, Amo T, Yamashiro K, Hattori N.
Saiki S, et al. Among authors: okuzumi a.
Sci Rep. 2017 Aug 4;7(1):7328. doi: 10.1038/s41598-017-06767-y.
Sci Rep. 2017.
PMID: 28779141
Free PMC article.